## Core Concept
The combination of medications in peptic ulcer disease (PUD) requires careful consideration to ensure efficacy and prevent adverse interactions. Ranitidine, a histamine H2-receptor antagonist, and sucralfate, a medication that forms a protective barrier over ulcers, are both used to treat PUD but work through different mechanisms.

## Why the Correct Answer is Right
Ranitidine decreases gastric acid secretion, while sucralfate works locally in the stomach to protect the ulcer site from acid and enzymes. The correct answer involves understanding the pharmacokinetic interaction that reduces the effectiveness of one or both drugs when used together.

## Why Each Wrong Option is Incorrect
To provide a thorough explanation, the correct answer must first be identified. Assuming the correct answer involves a drug interaction:

- **Option A:** This option might suggest a pharmacodynamic interaction leading to increased side effects, but this is not the primary concern with combining ranitidine and sucralfate.
- **Option B:** This could imply a lack of efficacy of one drug due to the other, which might be closer to the correct reason but needs clarification.
- **Option D:** This might propose an interaction not directly relevant to the combination of ranitidine and sucralfate.

## Clinical Pearl / High-Yield Fact
A key point to remember is that sucralfate requires an acidic environment to work effectively. Ranitidine, by reducing acid production, can interfere with sucralfate's mechanism of action. Therefore, it's generally recommended to administer these medications at least 2 hours apart to minimize this interaction.

## Correct Answer: C.
Sucralfate requires acidic environment to form complex with proteinaceous exudate at ulcer site and get activated. Ranitidine decreases acid production which may decrease efficacy of sucralfate.